Shikonin inhibits the proliferation and induces the apoptosis of human hepg2 cells

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 12, 2010, Pages 1138-1146

  Yingkun, Nie ^a   Lvsong, Zhu ^b   Huimin, Yu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Annexin v; Apoptosis; CD95; Cell cycle; Hepg2 cells; Shikonin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; FAS ANTIGEN; FLUOROURACIL; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; SHIKONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEGENERATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CHROMATIN; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CELL CARCINOMA; MICROVILLUS; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANNEXIN A5; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; ISOFLAVONES; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON; MITOCHONDRIA; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; S PHASE; SIGNAL TRANSDUCTION;

EID: 78650243853     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-085     Document Type: Article

References (32)

1. Brown, J.M., and Wouters, B.G. 1999. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59(7): 1391-1399. PMID:10197600.
2. Buolamwini, J.K. 2000. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6(4): 379-392. doi:10.2174/1381612003400948. PMID:10788588.
3. Bustamante, J., Caldas Lopes, E., Garcia, M., Di Libero, E., Alvarez, E., and Hajos, S.E. 2004. Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia. Toxicol. Appl. Pharmacol. 199(1): 44-51. doi:10.1016/j.taap.2004.03.021.PMID:15289089.
4. Cao, J., Liu, Y., Jia, L., Zhou, H.M., Kong, Y., Yang, G., et al. 2007. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic. Biol. Med. 43(6): 968-975. doi:10.1016/j.freeradbiomed.2007.06.006. PMID:17697941.
5. Chen, X., Yang, L., Oppenheim, J.J., and Howard, M.Z. 2002. Cellular pharmacology studies of shikonin derivatives. Phytother. Res. 16(3): 199-209. doi:10.1002/ptr.1100. PMID:12164262.
6. Chen, C.H., Chern, C.L., Lin, C.C., Lu, F.J., Shih, M.K., Hsieh, P.Y., and Liu, T.Z. 2003. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med. 69(12): 1119-1124. doi:10.1055/s-2003-45193. PMID:14750028.
7. Chipuk, J.E., and Green, D.R. 2005. Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 6(3): 268-275. doi:10.1038/nrm1573. PMID:15714200.
8. Danial, N.N., and Korsmeyer, S.J. 2004. Cell death: critical control points. Cell, 116(2): 205-219. doi:10.1016/S0092-8674(04)00046-7. PMID:14744432.
9. Gogvadze, V., and Orrenius, S. 2006. Mitochondrial regulation of apoptotic cell death. Chem. Biol. Interact. 163(1-2): 4-14. doi:10.1016/j.cbi.2006.04.010. PMID:16730343.
10. Green, D.R. 1998. Apoptotic pathways: the roads to ruin. Cell, 94(6): 695-698. doi:10.1016/S0092-8674(00)81728-6. PMID:9753316.
11. Hengartner, M.O. 2000. The biochemistry of apoptosis. Nature, 407(6805): 770-776. doi:10.1038/35037710. PMID:11048727.
12. Hsu, P.C., Huang, Y.T., Tsai, M.L., Wang, Y.J., Lin, J.K., and Pan, M.H. 2004. Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J. Agric. Food Chem. 52(20): 6330-6337. doi:10.1021/jf0495993. PMID:15453709.
13. Ishida, T., and Sakaguchi, I. 2007. Protection of human keratinocytes from UVB-induced inflammation using root extract of Lithospermum erythrorhizon. Biol. Pharm. Bull. 30(5): 928-934. doi:10.1248/bpb.30.928. PMID:17473437.
14. Kastan, M.B., and Bartek, J. 2004. Cell-cycle checkpoints and cancer. Nature, 432(7015): 316-323. doi:10.1038/nature03097.PMID:15549093.
15. Kim, P.K., Park, S.Y., Koty, P.P., Hua, Y., Luketich, J.D., and Billiar, T.R. 2003. Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells. J. Thorac. Cardiovasc. Surg. 125(6): 1336-1342. doi:10.1016/S0022-5223(02)73227-3. PMID:12830053.
16. Lee, H.J., Lee, H.J., Magesh, V., Nam, D., Lee, E.O., Ahn, K.S., et al. 2008. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in Lewis lung carcinoma-bearing mice. Yakugaku Zasshi, 128(11): 1681-1688. doi:10.1248/yakushi.128.1681. PMID:18981704.
17. Madan, E., Prasad, S., Roy, P., George, J., and Shukla, Y. 2008. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 377(4): 1232-1237. doi:10.1016/j.bbrc.2008.10.158.
18. McDonald, E.R. III, and El-Deiry, W.S. 2000. Cell cycle control as a basis for cancer drug development (Review). Int. J. Oncol. 16(5): 871-886. PMID:10762622.
19. Nagata, S., and Golstein, P. 1995. The Fas death factor. Science, 267(5203): 1449-1456. doi:10.1126/science.7533326. PMID: 7533326.
20. Nishizawa, M., Kohno, M., Nishimura, M., Kitagawa, A., and Niwano, Y. 2005. Presence of peroxyradicals in cigarette smoke and the scavenging effect of shikonin, a naphthoquinone pigment. Chem. Pharm. Bull. (Tokyo), 53(7): 796-799. doi:10.1248/cpb.53.796. PMID:15997138.
21. Papageorgiou, V.P., Assimopoulou, A.N., Couladouros, E.A., Hepworth, D., and Nicolaou, K.C. 1999. The chemistry and biology of alkannin, shikonin and related naphthazarin natural products. Angew. Chem. Int. Ed. 38(3): 270-301. doi:10.1002/(SICI) 1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0.
22. Thornberry, N.A. 1998. Caspases: key mediators of apoptosis. Chem. Biol. 5(5): R97-R103. doi:10.1016/S1074-5521(98)90615-9.
23. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods, 184(1): 39-51. doi:10.1016/0022-1759(95)00072-I. PMID:7622868.
24. Wang, L.M., Li, Q.Y., Zu, Y.G., Fu, Y.J., Chen, L.Y., Lv, H.Y., et al. 2008. Anti-proliferative and pro-apoptotic effect of CPT13, a novel camptothecin analog, on human colon cancer HCT8 cell line. Chem. Biol. Interact. 176(2-3): 165-172. doi:10.1016/j.cbi.2008.07.005. PMID:18708040.
25. Wang, W., Dai, M., Zhu, C., Zhang, J., Lin, L., Ding, J., and Duan, W. 2009. Synthesis and biological activity of novel shikonin analogues. Bioorg. Med. Chem. Lett. 19(3): 735-737. doi:10.1016/j.bmcl.2008.12.032. PMID:19111464.
26. Wu, Z., Wu, L., Li, L., Tashiro, S., Onodera, S., and Ikejima, T. 2004. p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells. J. Pharmacol. Sci. 94(2): 166-176. doi:10.1254/jphs.94.166. PMID:14978355.
27. Wu, Z., Wu, L.J., Tashiro, S., Onodera, S., and Ikejima, T. 2005. Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression in shikonin-induced HeLa cell apoptosis. Clin. Med. J. 118: 671-677.
28. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., et al. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275(5303): 1129-1132. doi:10.1126/science.275.5303.1129. PMID:9027314.
29. Yang, Y.H., Zhang, H., and Cao, R.Q. 1999. Effect of brassinolide on growth and shikonin formation in cultured onosma paniculatum cells. J. Plant Growth Regul. 18(2): 89-92. doi:10.1007/PL00007054. PMID:10552138.
30. Yang, H., Zhou, P., Huang, H., Chen, D., Ma, N., Cui, Q.C., et al. 2009. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Int. J. Cancer, 124(10): 2450-2459. doi:10.1002/ijc.24195. PMID:19165859.
31. Yeh, C.C., Kuo, H.M., Li, T.M., Lin, J.P., Yu, F.S., Lu, H.F., et al. 2007. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24). In Vivo, 21(6): 1011-1019. PMID:18210748.
32. Zhivotovsky, B., and Kroemer, G. 2004. Apoptosis and genomic instability. Nat. Rev. Mol. Cell Biol. 5(9): 752-762. doi:10.1038/nrm1443.